Allurefem Holding Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Allurefem Holding.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Construction	13.4%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

There's Reason For Concern Over Allurefem Holding Limited's (HKG:8305) Massive 28% Price Jump

Nov 01

Revenues Not Telling The Story For Allurefem Holding Limited (HKG:8305) After Shares Rise 28%

Aug 19

Allurefem Holding Limited's (HKG:8305) Shares Climb 43% But Its Business Is Yet to Catch Up

Jun 07

What Allurefem Holding Limited's (HKG:8305) P/S Is Not Telling You

Apr 18

Optimistic Investors Push Allurefem Holding Limited (HKG:8305) Shares Up 41% But Growth Is Lacking

Jan 03

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Allurefem Holding no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SEHK:8305 - Estimaciones futuras de los analistas y datos financieros pasados (HKD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	136	-14	11	11	N/A
3/31/2024	148	-28	N/A	N/A	N/A
12/31/2023	143	-30	7	7	N/A
9/30/2023	169	-33	N/A	N/A	N/A
6/30/2023	164	-36	8	8	N/A
3/31/2023	186	-22	N/A	N/A	N/A
12/31/2022	185	-25	7	7	N/A
9/30/2022	156	-47	N/A	N/A	N/A
6/30/2022	181	-43	-11	-11	N/A
3/31/2022	161	-44	N/A	N/A	N/A
12/31/2021	154	-43	-21	-21	N/A
9/30/2021	182	-5	N/A	N/A	N/A
6/30/2021	178	1	-3	-2	N/A
3/31/2021	159	-1	N/A	N/A	N/A
12/31/2020	173	-2	10	15	N/A
9/30/2020	178	-7	N/A	N/A	N/A
6/30/2020	198	-8	-6	2	N/A
3/31/2020	222	-2	N/A	N/A	N/A
12/31/2019	220	2	-34	-27	N/A
9/30/2019	239	19	N/A	N/A	N/A
6/30/2019	236	15	-25	-20	N/A
3/31/2019	238	12	N/A	N/A	N/A
12/31/2018	252	13	-9	-8	N/A
9/30/2018	238	4	N/A	N/A	N/A
6/30/2018	205	4	-21	-20	N/A
3/31/2018	189	4	N/A	N/A	N/A
12/31/2017	179	4	N/A	3	N/A
12/31/2016	134	11	N/A	3	N/A
12/31/2015	130	7	N/A	2	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 8305 es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 8305 crezcan más rápidamente que el mercado Hong Kong

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 8305 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 8305 crezcan más rápidamente que el mercado de Hong Kong.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 8305 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 8305 se prevé que sea elevada dentro de 3 años.

Allurefem Holding Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Tong Kee (Holding) Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2020

Recent updates

Allurefem Holding Limited has filed a Follow-on Equity Offering in the amount of HKD 11.55 million.

There's Reason For Concern Over Allurefem Holding Limited's (HKG:8305) Massive 28% Price Jump

Allurefem Holding Limited Appoints Shen Peng as Chief Executive Officer

Allurefem Holding Limited Appoints Shen Peng as Chief Executive Officer

Revenues Not Telling The Story For Allurefem Holding Limited (HKG:8305) After Shares Rise 28%

First half 2024 earnings released: EPS: HK$0.001 (vs HK$0.014 loss in 1H 2023)

Allurefem Holding Limited Announces Resignation of Heung Joe Tung as Non-Executive Director

Allurefem Holding Limited to Report First Half, 2024 Results on Aug 02, 2024

Allurefem Holding Limited's (HKG:8305) Shares Climb 43% But Its Business Is Yet to Catch Up

New major risk - Share price stability

What Allurefem Holding Limited's (HKG:8305) P/S Is Not Telling You

Full year 2023 earnings released: HK$0.029 loss per share (vs HK$0.023 loss in FY 2022)

Allurefem Holding Limited, Annual General Meeting, May 14, 2024

Allurefem Holding Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Optimistic Investors Push Allurefem Holding Limited (HKG:8305) Shares Up 41% But Growth Is Lacking

Third quarter 2023 earnings released: HK$0.001 loss per share (vs HK$0.004 loss in 3Q 2022)

Allurefem Holding Limited has filed a Follow-on Equity Offering in the amount of HKD 15.12 million.

Allurefem Holding Limited to Report Q3, 2023 Results on Nov 10, 2023

Is Allurefem Holding (HKG:8305) A Risky Investment?

Allurefem Holding Limited Appointment of Wang Tianwei as President of Greater China Region

Allurefem Holding Limited Appointment of Wang Tianwei as President of Greater China Region

Second quarter 2023 earnings released

Now 28% undervalued

Tong Kee (Holding) Limited to Report Q2, 2023 Results on Aug 11, 2023

A Look At The Fair Value Of Tong Kee (Holding) Limited (HKG:8305)

Now 24% undervalued

First quarter 2023 earnings released: HK$0.001 loss per share (vs HK$0.004 loss in 1Q 2022)

Now 20% undervalued

Now 27% undervalued after recent price drop

Less than half of directors are independent

Tong Kee (Holding) Limited to Report Q3, 2022 Results on Nov 15, 2022

Would Tong Kee (Holding) (HKG:8305) Be Better Off With Less Debt?

Second quarter 2022 earnings released: EPS: HK$0 (vs HK$0 in 2Q 2021)

Tong Kee (Holding) Limited to Report Q2, 2022 Results on Aug 10, 2022

CEO, Chairman & Compliance Officer recently bought HK$364k worth of stock

Insider recently sold HK$40m worth of stock

Would Tong Kee (Holding) (HKG:8305) Be Better Off With Less Debt?

First quarter 2022 earnings released: HK$0.004 loss per share (vs HK$0.003 loss in 1Q 2021)

Less than half of directors are independent

Tong Kee (Holding) Limited to Report Q1, 2022 Results on May 04, 2022

Is Tong Kee (Holding) (HKG:8305) Using Too Much Debt?

Third quarter 2021 earnings released: HK$0.001 loss per share (vs HK$0.006 profit in 3Q 2020)

Tong Kee (Holding) (HKG:8305) Is Making Moderate Use Of Debt

First quarter 2021 earnings released: HK$0.003 loss per share (vs HK$0.005 loss in 1Q 2020)

Is Tong Kee (Holding) (HKG:8305) Using Too Much Debt?

Full year 2020 earnings released: HK$0.003 loss per share (vs HK$0.003 profit in FY 2019)

Tong Kee (Holding) Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2020

Tong Kee (Holding) Limited to Report Fiscal Year 2020 Results on Mar 22, 2021

Third quarter 2020 earnings released: EPS HK$0.006

Tong Kee (Holding) Limited to Report Q3, 2020 Results on Nov 09, 2020

Earnings released

Tong Kee (Holding) Limited to Report Q2, 2020 Results on Aug 10, 2020

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento